- Home
- MRVI vs JILL Comparison
MRVI vs JILL Comparison
Compare MRVI & JILL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- JILL
- Stock Information
- Founded
- MRVI 2014
- JILL 1959
- Country
- MRVI United States
- JILL United States
- Employees
- MRVI N/A
- JILL N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- JILL Clothing/Shoe/Accessory Stores
- Sector
- MRVI Health Care
- JILL Consumer Discretionary
- Exchange
- MRVI Nasdaq
- JILL Nasdaq
- Market Cap
- MRVI 262.9M
- JILL 242.4M
- IPO Year
- MRVI 2020
- JILL 2017
- Fundamental
- Price
- MRVI $2.12
- JILL $16.90
- Analyst Decision
- MRVI Hold
- JILL Strong Buy
- Analyst Count
- MRVI 9
- JILL 5
- Target Price
- MRVI $6.54
- JILL $36.20
- AVG Volume (30 Days)
- MRVI 1.7M
- JILL 86.8K
- Earning Date
- MRVI 05-12-2025
- JILL 06-06-2025
- Dividend Yield
- MRVI N/A
- JILL 1.29%
- EPS Growth
- MRVI N/A
- JILL 3.98
- EPS
- MRVI N/A
- JILL 2.61
- Revenue
- MRVI $259,185,000.00
- JILL $610,857,000.00
- Revenue This Year
- MRVI N/A
- JILL $3.91
- Revenue Next Year
- MRVI $11.14
- JILL $3.30
- P/E Ratio
- MRVI N/A
- JILL $6.51
- Revenue Growth
- MRVI N/A
- JILL 0.46
- 52 Week Low
- MRVI $1.67
- JILL $14.37
- 52 Week High
- MRVI $11.56
- JILL $40.61
- Technical
- Relative Strength Index (RSI)
- MRVI 50.73
- JILL 55.60
- Support Level
- MRVI $1.96
- JILL $14.64
- Resistance Level
- MRVI $2.16
- JILL $16.12
- Average True Range (ATR)
- MRVI 0.12
- JILL 0.64
- MACD
- MRVI 0.04
- JILL 0.32
- Stochastic Oscillator
- MRVI 65.31
- JILL 72.28
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About JILL J. Jill Inc.
J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through its two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). Revenue is derived from the sale of apparel and accessory merchandise through the company's Retail and Direct channels, which include website and catalog phone orders. Revenue also includes shipping and handling fees collected from customers.